Solara Active Pharma Sciences Limited

Web: solara.co.in NSE: SOLARA BSE: 541540 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

637 7(1%)

Volume

40L as on 15, May

Open

659

High

725

Low

659

630

VWAP

560

52 Week High

712

52 Week Low

422

Viand Research Rating

Quality Score

62/100

Growth Score

61/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

3,043

No. of Shares

3.62

P/E

-7.25

P/B

3.56

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-49.14

ROCE

Profit Growth

Listing Date

27-Jun-18

Promoter Holding

42%

FII Holding

11.59%

DII Holding

3.75%

Price Chart

Price Performance

1 Week10%

1 Month18%

3 Months16%

6 Months14%

1 Year14%

YTD14%

Moving Average

5 Day SMA525

10 Day SMA520

20 Day SMA504

30 Day SMA496

50 Day SMA477

61 Day SMA477

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	537	513	525	545
Resistance 2	525	512	517	529
Resistance 1	516	510	512	525
Pivot Point	504	508	504	508
Support 1	496	506	496	504
Support 2	483	504	491	487
Support 3	475	502	483	483

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 42.00%	(0.01) 42.00%	(0.01) 42.01%	(4.11) 42.01%	(0.71) 37.94%	(0.01) 37.23%	(0.01) 37.27%	(6.81) 37.27%	(0.01) 30.49%	(-6.71) 30.49%	(-2.11) 37.19%	(-1.71) 39.31%	(0.61) 40.98%	(0.01) 40.41%	(0.01) 40.41%	(0.71) 40.40%	(0.21) 39.71%	(-1.61) 39.51%	(0.01) 41.07%
FIIs	(-0.41) 11.59%	(-1.61) 11.98%	(-0.71) 13.58%	(-0.41) 14.25%	(0.01) 14.63%	(0.41) 14.67%	(0.31) 14.25%	(-1.81) 14.00%	(-0.81) 15.80%	(-1.21) 16.62%	(-0.91) 17.86%	(-0.61) 18.71%	(0.01) 19.30%	(0.81) 19.26%	(0.51) 18.47%	(-1.51) 17.93%	(1.31) 19.42%	(0.91) 18.15%	(0.01) 17.28%
DIIs	(0.11) 3.75%	(1.01) 3.64%	(0.11) 2.69%	(0.01) 2.62%	(-0.61) 2.61%	(-0.21) 3.19%	(0.51) 3.37%	(-0.11) 2.83%	(1.21) 2.97%	(0.01) 1.75%	(0.01) 1.79%	(-1.01) 1.75%	(-0.31) 2.75%	(0.01) 3.01%	(-0.11) 2.97%	(-0.51) 3.10%	(-1.81) 3.64%	(-0.61) 5.40%	(0.01) 6.05%
Public	42.66%	42.37%	41.71%	41.10%	44.82%	44.92%	45.11%	45.89%	50.73%	51.14%	43.16%	40.22%	36.95%	37.32%	38.16%	38.57%	37.22%	36.94%	35.60%
No. of Shareholders	70,400	71,890	72,479	74,334	75,791	83,148	71,882	77,170	73,912	72,918	74,473	75,417	76,325	79,149	83,319	82,710	77,228	73,000	65,449

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	387.29	349	313.54	319.15	273.01	300.31	346.95	363.49	299.43	211.94	425.24	352.31	380.62	395	338	330	360.82	100.34	401.61	406
Sales Growth % (YoY)	41.9%	16.2%	-9.6%	-12.2%	-8.8%	41.7%	-18.4%	3.2%	-21.3%	-46.3%	25.7%	6.7%	5.5%	293.4%	-15.8%	-18.6%	-18.8%	-76.5%	1%	16.4%
Sales Growth % (QoQ)	11%	11.3%	-1.8%	16.9%	-9.1%	-13.4%	-4.6%	21.4%	41.3%	-50.2%	20.7%	-7.4%	-3.6%	16.9%	2.4%	-8.5%	259.6%	-75%	-1.1%	-
Expenses	329.63	311.66	278.81	262.13	227.64	242.63	285.64	321.57	289.67	373.63	387.61	333.19	331.85	350	311	318	347.29	197.18	329.75	314
Operating Profit	57.66	37.34	34.73	57.02	45.37	57.68	61.31	41.92	9.76	-161.69	37.63	19.12	48.77	45	28	13	13.53	-96.84	71.86	91
OPM %	14.89	10.7	11.08	17.87	16.62	19.21	17.67	11.53	3.26	-76.29	8.85	5.43	12.81	11	8	4	3.75	-96.51	17.89	23
Other Income	5.55	-6.75	0.49	0.98	5.95	1.49	0.32	0.56	-120.48	-62.32	-4.04	2.04	4.68	7	4	7	4.76	3.21	3.23	5
Interest	27.57	22.45	20.83	23.9	29.12	26.54	28.28	30.87	30.69	25.37	24.44	24.61	21.96	24	22	22	21.47	17.82	17.03	19
Depreciation	26.04	25.57	24.49	23.58	24.3	24.54	25.34	25.07	25.25	25.96	26.21	25.91	26.45	28	29	28	27.82	28.44	28.38	28
Profit before tax	9.6	-17.43	-10.1	10.52	-2.1	8.09	8.01	-13.46	-166.66	-275.34	-17.06	-29.36	5.04	1	-19	-31	-31	-139.89	29.68	50
Tax %	0	0	0	0	0	0	0	0	53.28	0	0	-34.91	25.4	22	-48	-47	-105.84	0	0	0
Net Profit	9.6	-17.43	-10.1	10.52	-2.1	8.09	8.01	-13.46	-255.45	-275.34	-17.06	-19.11	3.76	0	-10	-16	1.81	-139.89	29.68	50
Net Profit Growth % (QoQ)	155.1%	-72.6%	-196%	601%	-126%	1%	159.5%	94.7%	7.2%	-1514%	10.7%	-608.2%	100%	100%	37.5%	-984%	101.3%	-571.3%	-40.6%	-
Net Profit Growth % (YoY)	557.1%	-315.5%	-226.1%	178.2%	99.2%	102.9%	147%	29.6%	-6893.9%	100%	-70.6%	-19.4%	107.7%	100%	-133.7%	-132%	-	-	-	-
TTM Net Profit	-7.41	-19.11	6.41	24.52	0.539999999999999	-252.81	-536.24	-561.31	-566.96	-307.75	-32.41	-25.35	-22.24	-24.19	-164.08	-124.4	-58.4	-60.21	79.68	0
EPS in Rs	2.65	-4.82	-2.79	2.91	-0.58	2.24	2.22	-3.74	-53.2	-57.36	-3.58	-4.07	0.79	0.09	-2.08	-3.42	0.39	-29.2	6.2	10.47

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	1369	1284	1289	1444	1268	1617	1322	1387	521
Sales Growth %	6.6%	-0.4%	-10.7%	13.8%	-21.6%	22.3%	-4.7%	166.2%	-
Expenses	1182	1077	1384	1309	1188	1231	1062	1174	464
Operating Profit	187	206	-95	134	81	386	260	213	57
OPM %	14	16	-7	9	6	24	20	15	11
Other Income	0	8	-185	22	16	29	27	12	2
Interest	95	115	105	90	75	84	78	82	25
Depreciation	100	99	103	111	112	109	94	83	34
Profit before tax	-7	1	-488	-45	-91	222	115	60	0
Tax %	0	0	16	-50	-36	0	0	1	-70
Net Profit	-7	1	-567	-22	-58	221	115	59	0
Net Profit Growth %	-800%	100.2%	-2477.3%	62.1%	-126.2%	92.2%	94.9%	-	-
EPS in Rs	-2.05	0.15	-118.21	-4.62	-12.11	46.22	32.01	17.3	0
Dividend Payout %	0	0	0	-49	0	11	5	22	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	153	213	109	156	-242	155	242	166	49
Cash from Investing Activity	-99	-37	-4	-81	-243	-106	-359	-113	-85
Cash from Financing Activity	-54	-180	-106	-113	334	92	97	-23	68
Net Cash Flow	1	-4	0	-38	-151	142	-20	30	31

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	45	44	40	40	36	36	36	36	27	26	25
Reserves	1208	1210	1054	1046	898	1464	1489	1553	1059	930	739
Borrowings	687	646	796	840	1012	1013	1037	621	722	538	633
Other Liabilities	393	393	342	364	406	386	383	404	346	466	425
Total Liabilities	2333	2293	2232	2290	2351	2899	2945	2614	2153	1960	1821
Fixed Assets	1238	1232	1193	1231	1268	1364	1356	1382	1397	1218	1086
CWIP	205	230	280	272	256	238	239	88	40	40	71
Investments	5	2	2	2	2	2	0	0	0	0	1
Other Assets	886	829	757	786	825	1295	1350	1144	716	701	663
Total Assets	2333	2293	2232	2290	2351	2899	2945	2614	2153	1960	1821

Delivery

Delivery Data: SOLARA

#	Date	472 43% 674	Value (Cr)	Q/T 32	Del 37	Del 24
1	4-Sep	639	25	29	43	11
2	3-Sep	630	14	27	49	7
3	2-Sep	640	22	24	47	11
4	1-Sep	643	70	28	36	25
5	31-Aug	633	14	22	37	5
6	28-Aug	624	12	21	32	4
7	27-Aug	612	14	18	47	7
8	26-Aug	617	20	25	44	9
9	25-Aug	629	22	23	34	8
10	24-Aug	629	39	34	32	12
11	21-Aug	617	46	38	25	11
12	20-Aug	640	433	49	11	47
13	19-Aug	550	7	17	48	3
14	18-Aug	549	36	33	32	12
15	17-Aug	509	4	16	49	2
16	14-Aug	512	4	18	56	2
17	13-Aug	518	6	23	48	3
18	12-Aug	506	3	19	46	1
19	11-Aug	509	7	27	63	4
20	10-Aug	514	11	23	56	6
21	7-Aug	503	8	29	64	5
22	6-Aug	511	4	25	57	2
23	5-Aug	515	4	30	63	3
24	4-Aug	521	7	47	61	4
25	3-Aug	516	6	28	58	3
26	31-Jul	514	6	27	64	4
27	30-Jul	508	8	28	52	4
28	29-Jul	506	6	28	50	3
29	28-Jul	507	10	29	60	6
30	27-Jul	505	29	31	41	12
31	24-Jul	492	31	29	48	15
32	23-Jul	524	89	27	19	17
33	22-Jul	536	25	29	41	10
34	21-Jul	559	6	22	54	3
35	20-Jul	570	4	15	48	2
36	17-Jul	571	8	17	55	4
37	16-Jul	578	4	24	50	2
38	15-Jul	578	5	15	44	2
39	14-Jul	576	9	22	42	4
40	13-Jul	585	16	27	46	7
41	10-Jul	569	48	33	43	21
42	9-Jul	567	20	29	58	12
43	8-Jul	560	21	25	46	10
44	7-Jul	560	5	20	46	2
45	6-Jul	560	8	27	55	5
46	3-Jul	576	10	26	51	5
47	2-Jul	572	12	25	54	7
48	1-Jul	566	8	24	47	4
49	30-Jun	576	10	23	55	5
50	29-Jun	572	10	26	50	5

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	3,043c	48L	0.02
03-Sep	3,042c	108c	3.41
01-Sep	3,150c	92c	2.99
31-Aug	3,058c	126c	4.30
27-Aug	2,932c	49c	1.63
26-Aug	2,981c	18c	0.60
25-Aug	2,999c	3c	0.10
24-Aug	3,002c	7c	0.22
21-Aug	3,008c	384c	14.64
19-Aug	2,624c	19c	0.73
18-Aug	2,643c	213c	8.75
17-Aug	2,431c	7c	0.29
14-Aug	2,438c	31c	1.25
13-Aug	2,469c	52c	2.16
12-Aug	2,416c	78c	3.13
11-Aug	2,495c	0	0
10-Aug	2,495c	91c	3.77
07-Aug	2,404c	53c	2.15
06-Aug	2,457c	8c	0.32
05-Aug	2,465c	8c	0.34
04-Aug	2,473c	12c	0.49
31-Jul	2,461c	14c	0.57
30-Jul	2,447c	43c	1.79
29-Jul	2,404c	23c	0.95
28-Jul	2,427c	28c	1.19
27-Jul	2,399c	0	0

Stock Checklist

Price is above from 52 week high low average: 74%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 6 fund scheme(s) across 3 fund house(s) as of Aug26 · Total value ₹43 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Aditya Birla Sun Life Mutual Fund	2	0.08%	-	43.1
Bandhan Mutual Fund	2	0.10%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Solara Active Pharma Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements